424B3: Prospectus
16:25 ET
EFFECT: Others
Apr 18 06:06 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Apr 12 16:20 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Officer Audet Juliette Berangere
Apr 2 16:37 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
Apr 1 08:21 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Topper James N
Mar 28 16:36 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Officer Kastelein Johannes Jacob Pieter
Mar 27 16:36 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 26 17:40 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 424B3: Prospectus
Mar 12 16:26 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | EFFECT: Others
Mar 11 06:06 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
Mar 4 08:10 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BCLS Fund III Investments, LP(6.0%),BCLS II Investco, LP(5.4%), etc.
Mar 1 16:37 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Feb 28 17:19 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
Feb 28 08:12 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 10-K: Annual report
Feb 28 08:02 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director LANGE LOUIS G
Feb 21 17:08 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James N. Topper(14.2%),Patrick J. Heron(14.2%), etc.
Feb 21 11:15 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
Feb 15 16:25 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 424B5: Prospectus
Feb 15 16:18 ET
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.9%),Peter Kolchinsky(9.9%), etc.
Feb 14 17:31 ET
No Data
No Data